Connection
Nanette Santoro to Comorbidity
This is a "connection" page, showing publications Nanette Santoro has written about Comorbidity.
|
|
Connection Strength |
|
|
|
|
|
0.146 |
|
|
|
-
Santoro N, Lo Y, Moskaleva G, Arnsten JH, Floris-Moore M, Howard AA, Adel G, Zeitlian G, Schoenbaum EE. Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women. Menopause. 2007 Sep-Oct; 14(5):859-65.
Score: 0.053
-
Santoro N, Arnsten JH, Buono D, Howard AA, Schoenbaum EE. Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle-aged women. J Womens Health (Larchmt). 2005 Dec; 14(10):898-905.
Score: 0.047
-
Maruotti N, D'Onofrio F, Neve A, Santoro N, Corrado A, Cantatore FP. Anti-TNF-a and risk of infections: the experience in one center. Panminerva Med. 2014 Mar; 56(1):31-4.
Score: 0.021
-
Pal L, Hailpern SM, Santoro NF, Freeman R, Barad D, Kipersztok S, Barnabei VM, Wassertheil-Smoller S. Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial. Menopause. 2008 Jan-Feb; 15(1):59-66.
Score: 0.014
-
Miller SA, Santoro N, Lo Y, Howard AA, Arnsten JH, Floris-Moore M, Moskaleva G, Schoenbaum EE. Menopause symptoms in HIV-infected and drug-using women. Menopause. 2005 May-Jun; 12(3):348-56.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|